A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Follicular Lymphoma

Type of Cancer
Lymphoma

Sponsor
Incyte

Protocol Number
INCB 50465-203

To Learn More Call
201-510-0910